Published in J Clin Psychopharmacol on December 01, 1993
Letter regarding "Response to antidepressants and cancer: cause for concern?". J Clin Psychopharmacol (1995) 1.41
Effects of nefazodone on the development of experimentally induced tumors in stressed rodents. Psychopharmacology (Berl) (2004) 0.75
Antidepressants and cancer: cause for concern? J Clin Psychopharmacol (1993) 2.43
Clinical characteristics of patients with concurrent major depressive disorder and panic disorder. Am J Psychiatry (1994) 0.96
Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy. Biol Psychiatry (1997) 0.79
Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatry Res (1994) 0.79
Major depressive disorder and panic disorder. Effects of comorbidity on treatment outcome with antidepressant medications. Clin Neuropharmacol (1988) 0.79
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder. J Clin Psychopharmacol (1995) 0.78
Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic. Biol Psychiatry (1993) 0.78
Two year follow-up of atypical depression. J Psychiatr Res (1999) 0.77
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients. Psychopharmacology (Berl) (1997) 0.77
Seasonal symptom variation in patients with chronic fatigue: comparison with major mood disorders. J Psychiatr Res (1994) 0.77
Shortened REM latency PostECT is associated with rapid recurrence of depressive symptomatology. Biol Psychiatry (1994) 0.76
Clonazepam treatment of atypical bipolar disorder. Psychosomatics (1988) 0.76
Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry (1996) 0.76
Lithium associated with psoriasis. J Clin Psychiatry (1986) 0.76
EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder. Biol Psychiatry (1992) 0.76
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder. Psychiatry Res (1999) 0.75
Treatment of resistant depression with 5-HT uptake inhibitors. Clin Neuropharmacol (1992) 0.75
Sublingual lorazepam use. Can J Psychiatry (1987) 0.75
Midwinter insomnia. Acta Psychiatr Scand (1986) 0.75
Co-existence of incubus and Capgras syndromes. Br J Psychiatry (1981) 0.75
Heterogeneity in the beta-endorphin immunoreactivity response to electroconvulsive therapy. Arch Gen Psychiatry (1991) 0.75
A dystonic reaction occurring during treatment with tranylcypromine. J Clin Psychopharmacol (1989) 0.75
Pharmacological treatments of SAD. Can J Psychiatry (1990) 0.75
Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors. Acta Psychiatr Scand (1990) 0.75
Polysomnographic studies in patients referred for ECT: pre-ECT studies. Convuls Ther (1996) 0.75
Sleep Electroencephalographic Studies After ECT. Am J Geriatr Psychiatry (1994) 0.75
Light-induced hypomania. Am J Psychiatry (1985) 0.75